phenidone has been researched along with Encephalopathy, Toxic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bing, G; Choi, DY; Hunter, RL; Jin, CH; Kim, HC; Kim, MS; Li, Z; Park, SJ; Shin, EJ; Wie, MB | 1 |
| Cho, YJ; Jhoo, WK; Kim, HC; Wie, MB | 1 |
2 other study(ies) available for phenidone and Encephalopathy, Toxic
| Article | Year |
|---|---|
Phenidone protects the nigral dopaminergic neurons from LPS-induced neurotoxicity.
Topics: Analysis of Variance; Animals; CD11b Antigen; Cyclooxygenase Inhibitors; Disease Models, Animal; Dopamine; Drug Interactions; Lipopolysaccharides; Male; Neurons; Neurotoxicity Syndromes; Pyrazoles; Rats; Rats, Sprague-Dawley; Substantia Nigra | 2008 |
Phenidone attenuates oxygen/glucose deprivation-induced neurotoxicity by antioxidant and antiapoptotic action in mouse cortical cultures.
Topics: Animals; Antioxidants; Apoptosis; Cell Line; Cerebral Cortex; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Glucose; Hydrogen Peroxide; Kainic Acid; Lipoxygenase Inhibitors; Mice; Mice, Inbred Strains; Microscopy, Phase-Contrast; Neuroglia; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidants; Oxygen; Pyrazoles | 1999 |